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Is more radical more effective?Chen et al have published an interesting article entitled Is
conization once following by simple hysterectomy sufficient
for all clinical stage IA1 cervical squamous cell carcinoma?
[1]. The authors found that only 4.2% of simple hysterec-
tomies (SH; 2/48) needed postoperative adjuvant radiation
[1]. Based on our understanding, only two patients had an up-
staged pathological diagnosis (>T1a1 squamous cell carci-
noma), and were given a so-called inadequate treatment, so
they needed adjuvant therapy. By contrast, >95% of much
more extensive surgeries (for example, modified radical
hysterectomy) could be avoided for these patients, although
the accurate percentage might be only 89.7%, since 68
patients had at least one risk factor in the cone specimens.
We congratulate Chen et al for the success of their work.
However, since this study challenged an old conceptdthe
more radical, the more effectivedsome issues need to be
discussed.
First, how many patients or what percentage of patients
who are given so-called inadequate treatment should we
accept? It is not easy to respond to this question. For example,
the cut-off value of the maternal serum Downs screening test
is 1/270 [2,3], and laparoscopic cystectomy of ovarian mature
teratoma is considered as a treatment of choice, based on the
low incidence of malignant transformationdrepresenting
<0.5% [4]. Now, in Chen et al’s report, it is 4.2%, which is
nearly 5% by self-reporting, but 10.3% by accurate reporting if
these 68 patients were all treated with SH. Is this acceptable?
In addition, if the cases of reconization were added into the
data pool for analysis, the percentage of upgraded cases might
be as high as 23.8% (19/80). It is questionable whether
physicians can accept the conclusion reached by the authors,
that extra-fascial SH may be recommended for all clinical
T1a1 cervical squamous cell carcinomas, regardless of the
pathologic risk factors [1].
Second, the risk of lymph node metastases should be con-
sidered, since nearly 3% and 15% of the FIGO stage IA2 and
IB cases showed metastases of the pelvic lymph nodes, sug-
gesting that the authors failed to discuss an important
issuedthe necessity of lymphadenectomy [5,6]. That is
another limitation of this article, which focused only on types
of hysterectomy in the management of microinvasive squ-
amous cell carcinoma on cone specimens.
Finally, the type of rescue therapy for inadequate surgery
to deal with squamous cell carcinoma of the cervix could be1028-4559/$ - see front matter Copyright  2013, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2013.04.002discussed, including reoperation or concurrent chemo-
radiation. Adjuvant therapy with radiotherapy might not be a
better choice, since much evidence supports the better tumor
control and disease-free survival when concurrent chemo-
radiation is used as adjuvant therapy, compared with radia-
tion alone [7].
In conclusion, sometimes it is hard to make the decision on
how much radical surgery is enough [8], although a delicate
surgical method for cancer treatment is always welcome [9] and
better teamwork is always of value [10,11]. Although more
evidence is needed, this paper has provided an excellent basis for
the reconsideration of the necessity of radical surgery [1].References
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